G01N 2800/125
Adult respiratory distress syndrome
G01N2800/125 (Adult respiratory distress syndrome) appears on 31 US grants and 53 published applications in this corpus.
Search patents in G01N- Granted patents
- 31
- Published applications
- 53
- Assignees
- 34
- Inventors
- 83
- Latest grant
- 14 Apr 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2001 | 1 | 0 |
| 2002 | 2 | 1 |
| 2003 | 0 | 2 |
| 2004 | 0 | 0 |
| 2005 | 0 | 1 |
| 2006 | 3 | 3 |
| 2007 | 1 | 0 |
| 2008 | 0 | 2 |
| 2009 | 2 | 1 |
| 2010 | 0 | 1 |
| 2011 | 1 | 2 |
| 2012 | 1 | 4 |
| 2013 | 0 | 1 |
| 2014 | 4 | 1 |
| 2015 | 2 | 8 |
| 2016 | 2 | 4 |
| 2017 | 0 | 1 |
| 2018 | 2 | 2 |
| 2019 | 2 | 3 |
| 2020 | 1 | 1 |
| 2021 | 1 | 2 |
| 2022 | 1 | 2 |
| 2023 | 0 | 5 |
| 2024 | 2 | 3 |
| 2025 | 1 | 2 |
| 2026 | 2 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Treatment of ARDS and other conditions caused by acutely elevated cytokine levels and post ARDS chronic cytokine production using inhaled anesthetics14 Apr 2026US 12,599,625 B2Penland Foundation
- Compositions and methods for treating pulmonary edema or lung inflammation10 Mar 2026US 12,569,459 B2Regents of the University of Minnesota
- Generation of alveolar epithelial type 1 (AT1) cells10 Jun 2025US 12,324,818 B2Trustees of Boston University
- Methods for categorizing and treating subjects having cystic fibrosis (CF) and at risk for severe pulmonary exacerbation19 Nov 2024US 12,146,875 B2National Jewish Health
- Method for assisting prediction of exacerbation of respiratory infection, and device to assist in predicting exacerbation of respiratory infection19 Nov 2024US 12,146,887 B2National Center for Global Health and Medicine
- Method of selecting patients for treatment with an il-33 axis antagonist26 Feb 2026US 2026/0056210 A1MedImmune, LLC
- Generation of alveolar epithelial type 1 (at1) cells28 Aug 2025US 2025/0268947 A1Trustees of Boston University
- Methods for Categorizing and Treating Subjects at Risk for Pulmonary Exacerbation and Disease Progression30 Jan 2025US 2025/0035617 A1National Jewish Health
- Generation of alveolar epithelial type 1 (at1) cells8 Aug 2024US 2024/0261337 A1Trustees of Boston University
- Method of prognosis8 Aug 2024US 2024/0264173 A1Plaquetec Ltd.
Most cited
By later US patents
- Methods for diagnosing sepsis57US 6,303,321 B1North Shore-Long Island Jewish Research Institute · 2001
- Methods for detection of IL-18 as an early marker for diagnosis of acute renal failure and predictor of mortality35US 7,141,382 B12006
- Antagonists of HMG1 for treating inflammatory conditions30US 6,468,533 B1North Shore-Long Island Jewish Research Institute · 2002
- Antagonists of HMG1 for treating inflammatory conditions24US 6,448,223 B1North Shore-Long Island Jewish Research Institute · 2002
- Antagonists of HMG1 for treating inflammatory conditions14US 7,097,838 B2The Feinstein Institute for Medical Research · 2006